Green Park & Golf Ventures Company Profile

Background

Green Park & Golf Ventures is a Dallas-based venture capital firm with over 60 years of combined operational and financial experience. Founded by Dr. Clay Heighten, M.D., and Carl Soderstrom, the firm specializes in early-stage investments in medical-related startups, aiming to deliver above-market returns for its investors. The firm's mission is to provide strategic solutions, financial backing, and a reliable network to its portfolio companies, focusing on innovative healthcare solutions. Their vision centers on fostering companies that treat others with compassion, dignity, and respect, while introducing disruptive ideas to the healthcare market.

Key Strategic Focus

Green Park & Golf Ventures' investment strategy is grounded in methodologies that have been successful in building companies like MedicalEdge and PhyServe. The firm seeks:

Compassionate Companies: Organizations that prioritize treating others with compassion, dignity, and respect.

Innovative Ideas: Startups with fresh, potentially disruptive concepts in their market space.

Experienced Management Teams: Passionate, seasoned, and energetic management teams of two or more individuals.

Large Market Opportunities: Companies targeting large markets with high barriers to entry.

Aligned Incentives: Alignment of incentives across owners, management, and employees.

The firm typically invests between $500,000 and $2,000,000, providing either start-up or growth capital, depending on the entrepreneur's needs and the company's life stage.

Financials and Funding

Green Park & Golf Ventures has established a strong financial foundation through its investments and funds:

GPGV Follow-On Investment Fund: In June 2017, the firm closed on a third of its $30 million follow-on investment fund, aiming to support 15 to 20 companies over the next four to five years.

GPG Healthcare Opportunities Fund (GPG HOF): In 2018, the firm closed its first fund with $9.1 million, followed by a second fund in 2021 with $20.5 million. These funds invest exclusively in healthcare and healthcare-related portfolio companies, with GPG having sole discretion over the investment of committed capital.

Pipeline Development

Green Park & Golf Ventures has a diverse portfolio of investments across various stages of development:

Medical Devices: Investments include companies like Empirical Spine, Esculon, MicroTransponder Inc., Corvion, RTRS Technologies (Replicate Dental), Accuryn, Channel Medsystems, Ataia Medical, and Novascan.

Therapeutics: The firm has invested in Lantern Pharma, Betaliq, Inc., Stingray Therapeutics, OncoNano Medicine, Barricade Therapeutics, and Iterion Therapeutics.

Diagnostics: Investments include Gregor Diagnostics, Maui Imaging, and Prolocor.

Consumer Health: The firm has invested in Grow Happy.

Tech/SaaS: Investments include AdBm Technologies Inc., HyperGiant Industries, Avanta Risk Management, Work Shield, OneDay, Alto, Earthview, and CounterFind.

Technological Platform and Innovation

Green Park & Golf Ventures distinguishes itself through its focus on innovative technologies and platforms:

Proprietary Technologies: The firm has invested in companies developing proprietary technologies such as Noninvasix's non-invasive precision oximetry system and MicroTransponder's implantable neurostimulation platforms.

Scientific Methods: Investments like Lantern Pharma utilize AI and machine learning platforms to transform oncology drug discovery and development.

Leadership Team

The leadership team at Green Park & Golf Ventures comprises:

Dr. Clay Heighten: Founding member with a background in healthcare, having founded MedicalEdge Healthcare Group in 1993.

Carl Soderstrom: Founding partner with experience in physician services, having started PhyServe Physician Services in 1998.

JR Garcia: Principal & VP of Investments, joined the firm in 2011, bringing experience from FedEx, Bold Ventures, and Lone Star Investment Advisors.

Dr. Lauren Tyra: Analyst since 2017, with a background in neuroscience.

Daniel S. Parsley: Managing Partner of GPG Ventures – Houston, with experience in early-stage medical device and biotech investments.

John Leader: Principal in charge of Investment Operations since 2019, overseeing deal pipeline and evaluation of potential investments.

Claire England: Investment Partner since 2023, leading the firm's Austin presence.

Market and Competitive Landscape

The healthcare venture capital market is dynamic, with growing emphasis on innovative medical devices, therapeutics, diagnostics, and healthcare IT solutions. The increasing demand for healthcare innovation presents significant opportunities for firms like Green Park & Golf Ventures.

Key competitors in the space include Capital Factory, Dallas Venture Capital, and Perot Jain. These firms also focus on early-stage investments in technology and healthcare sectors, contributing to a competitive landscape.

Green Park & Golf Ventures collaborates with organizations such as TheraNova, Health Wildcatters, Healthx, and Tricera Labs to foster innovation and support portfolio companies.

The firm’s extensive network and experience enable superior deal flow, allowing it to identify and support promising startups effectively. Its focus on compassionate and innovative companies, alongside investment in disruptive technologies, differentiates it in the market.

Strategic Opportunities and Future Directions

Green Park & Golf Ventures is positioned to capitalize on emerging healthcare trends, including telemedicine, personalized medicine, and AI-driven healthcare solutions. Its strategic roadmap includes expanding its portfolio in these areas and leveraging its network to drive growth and innovation.